RNA · NASDAQ · Biotechnology

Atrium Therapeutics

Targets genetic drivers of rare cardiomyopathies with tissue-directed siRNA medicines.

$13.64
After-hours close+0.01 (+0.07%)
At close$13.63(−2.50%)
DateEstimateReportedSurprise
Nov 2026−$0.87
Aug 2026−$1.42−$1.18+16.9%
May 2026−$1.05−$0.97+7.6%
Feb 2026−$1.24−$0.61+50.8%
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 12, 2026−$0.87$15.0M
Aug 13, 2026−$1.42−$1.18+16.9%$666.7K$3.0M+350.6%
May 14, 2026−$1.05−$0.97+7.6%$2.0M$19.6M+881.8%
Feb 26, 2026−$1.24−$0.61+50.8%$2.0M$2.1M+6.0%